scPharmaceuticals (SCPH) Competitors $3.97 -0.07 (-1.73%) As of 07/3/2025 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SCPH vs. CMRX, CDMO, AVXL, SION, QURE, AVBP, CRON, XERS, PHAR, and REPLShould you be buying scPharmaceuticals stock or one of its competitors? The main competitors of scPharmaceuticals include Chimerix (CMRX), Avid Bioservices (CDMO), Anavex Life Sciences (AVXL), Sionna Therapeutics (SION), uniQure (QURE), ArriVent BioPharma (AVBP), Cronos Group (CRON), Xeris Biopharma (XERS), Pharming Group (PHAR), and Replimune Group (REPL). These companies are all part of the "pharmaceutical products" industry. scPharmaceuticals vs. Its Competitors Chimerix Avid Bioservices Anavex Life Sciences Sionna Therapeutics uniQure ArriVent BioPharma Cronos Group Xeris Biopharma Pharming Group Replimune Group scPharmaceuticals (NASDAQ:SCPH) and Chimerix (NASDAQ:CMRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership. Does the media favor SCPH or CMRX? In the previous week, scPharmaceuticals' average media sentiment score of 0.00 equaled Chimerix'saverage media sentiment score. Company Overall Sentiment scPharmaceuticals Neutral Chimerix Neutral Which has more volatility & risk, SCPH or CMRX? scPharmaceuticals has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Chimerix has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500. Do insiders and institutionals hold more shares of SCPH or CMRX? 89.5% of scPharmaceuticals shares are owned by institutional investors. Comparatively, 45.4% of Chimerix shares are owned by institutional investors. 4.8% of scPharmaceuticals shares are owned by company insiders. Comparatively, 13.1% of Chimerix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation and earnings, SCPH or CMRX? Chimerix has lower revenue, but higher earnings than scPharmaceuticals. Chimerix is trading at a lower price-to-earnings ratio than scPharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioscPharmaceuticals$36.33M5.77-$85.15M-$1.91-2.08Chimerix$212K3,778.71-$82.10M-$0.99-8.63 Do analysts prefer SCPH or CMRX? scPharmaceuticals currently has a consensus target price of $14.00, indicating a potential upside of 252.64%. Chimerix has a consensus target price of $8.53, indicating a potential downside of 0.08%. Given scPharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe scPharmaceuticals is more favorable than Chimerix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score scPharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Chimerix 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is SCPH or CMRX more profitable? Chimerix has a net margin of 0.00% compared to scPharmaceuticals' net margin of -216.24%. Chimerix's return on equity of -50.78% beat scPharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets scPharmaceuticals-216.24% -594.07% -73.54% Chimerix N/A -50.78%-44.94% SummaryscPharmaceuticals and Chimerix tied by winning 7 of the 14 factors compared between the two stocks. Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCPH vs. The Competition Export to ExcelMetricscPharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$209.58M$2.90B$5.53B$9.05BDividend YieldN/A2.44%5.24%4.02%P/E Ratio-2.0821.5627.5120.24Price / Sales5.77281.76416.89118.64Price / CashN/A42.7336.8958.07Price / Book14.707.518.035.67Net Income-$85.15M-$55.05M$3.18B$249.13M7 Day Performance2.58%4.61%2.90%3.28%1 Month Performance-3.41%4.72%3.71%5.56%1 Year Performance-9.98%5.92%36.03%21.13% scPharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCPHscPharmaceuticals4.1673 of 5 stars$3.97-1.7%$14.00+252.6%-6.6%$209.58M$36.33M-2.0830CMRXChimerix0.6341 of 5 stars$8.54flat$8.53-0.1%N/A$801.09M$212K-9.0990CDMOAvid Bioservices0.7045 of 5 stars$12.50+0.1%$12.25-2.0%+62.3%$799.18M$139.91M-5.23320High Trading VolumeAVXLAnavex Life Sciences3.6088 of 5 stars$9.22-2.7%$44.00+377.2%+160.2%$787.13MN/A-16.7640SIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$765.48MN/A0.0035Positive NewsInsider TradeQUREuniQure1.9811 of 5 stars$13.94+0.6%$37.82+171.3%+270.5%$763.63M$27.12M-3.18500News CoverageAVBPArriVent BioPharma1.7483 of 5 stars$21.77-5.0%$40.00+83.7%+13.6%$744.75MN/A-5.7740CRONCronos Group2.2939 of 5 stars$1.91+0.5%N/A-12.1%$736.65M$117.61M14.69450News CoverageXERSXeris Biopharma3.9038 of 5 stars$4.67-0.6%$6.25+33.8%+128.6%$730.30M$203.07M-15.57290Positive NewsPHARPharming Group2.9053 of 5 stars$10.68-2.9%$30.00+181.0%+23.1%$726.29M$297.20M-53.38280Positive NewsGap DownHigh Trading VolumeREPLReplimune Group4.1867 of 5 stars$9.29-0.4%$20.83+124.3%+16.8%$719.22MN/A-3.03210News CoverageAnalyst Forecast Related Companies and Tools Related Companies Chimerix Alternatives Avid Bioservices Alternatives Anavex Life Sciences Alternatives Sionna Therapeutics Alternatives uniQure Alternatives ArriVent BioPharma Alternatives Cronos Group Alternatives Xeris Biopharma Alternatives Pharming Group Alternatives Replimune Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCPH) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCPH Stock Alerts